Market Cap | 31.76K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -1.95M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 69.00% |
Sales | 1.27k | PEG | - | EPS past 5Y | - | 200D Avg Chg | 68.00% |
Dividend | N/A | Price/Book | 0.02 | EPS next 5Y | - | 52W High Chg | - |
Recommedations | - | Quick Ratio | 124.34 | Shares Outstanding | 158.79M | 52W Low Chg | 100.00% |
Insider Own | - | ROA | -129.95% | Shares Float | - | Beta | -35.34 |
Inst Own | 0.07% | ROE | -213.57% | Shares Shorted/Prior | -/- | Price | 0.00020 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 11,231 | Target Price | - |
Oper. Margin | -424,549.20% | Earnings Date | - | Volume | 3,352 | Change | 0.00% |
NanoLogix, Inc., a biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. The company's products include BioNanoPore kit, which employs a water permeable membrane that works with organic and inorganic molecules, as well as proteins; and FlatPack Petri Plates that are used for the isolation and cultivation of various fastidious and non-fastidious microorganisms, as well as displays growth of aerobic and anaerobic microorganisms. Its products are used in medical, national defense, homeland security, pharmaceutical, industrial, veterinary, and environmental testing applications. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. NanoLogix, Inc. is based in Hubbard, Ohio.